delivering long-term success in cannabis...

cgocorp.com 1

CSE : CGOC

NOVEMBER 2019

CORPORATE PRESENTATION

Long-term Success

in Cannabis Investing

cgocorp.com 2

Disclaimer

The presented materials and accompanying oral presentation may constitute “forward-looking information” within the meaning of Canadian securities laws and are based on expectations,

estimates and projections as of the date of this presentation. Forward-looking statements include, without limitation, statements with respect to:

a) the completion of the Offering and receipt of all regulatory approvals in connection therewith;

b) the use of the net proceeds of the Offering;

c) the availability of investment opportunities;

d) the performance of the Corporation’s business and operations;

e) applicable laws, regulations and any amendments thereof including, but not limited to, the legalization of cannabis and the timing thereto;

f) the competitive and business strategies of the Corporation;

g) statements related to the effect and consequences of certain regulatory initiatives;

h) the expected growth of the cannabis sector;

i) the competitive conditions of the industry;

j) the Corporation’s investments in the U.S. and consequences of those investments under U.S. federal law; and

k) the anticipated changes to laws regarding the recreational use of cannabis and the business impacts on the Corporation

Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of

specific factors and assumptions that, while considered reasonable by management as of the date on which the statements are made in this presentation, are inherently subject to significant

business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being incorrect. In addition to the various factors and

assumptions set forth in this presentation, the material factors and assumptions used to develop the forward-looking information include, but are not limited to: general economic, financial

market, regulatory and political conditions in which the Corporation operates will continue to improve; the Corporation will be able to compete in the industry; the Corporation will be able to

make investments on suitable terms; issuers in the Portfolio will be able to meet their objectives and financial estimates and that the risk factors noted below, collectively, do not have a

material impact on the Corporation.

By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be

accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. Known and unknown risk factors, many of which are beyond the control of the Corporation could cause actual results to differ

materially from the forward-looking information in this presentation. Such factors, without limitation, include the following, which are discussed in greater detail in the “Risk Factors” section of the Prospectus: there is no assurance that the Corporation

will be able to achieve its investment objectives; risks relating to the Portfolio issuers; risks relating to medical cannabis; risks relating to risk and timing of legalization of recreational cannabis; regulatory risks; risks relating to the performance of the

Portfolio issuers; risks relating to the licensing process; no current market for Common Shares or Warrants; risks relating to recent and future global financial developments; industry concentration risks; risks associated with investment in illiquid and

private securities; risk factors related to U.S. cannabis legislation; changes to the cannabis laws; United States anti-money laundering laws and regulations; investments in U.S. cannabis sector; short selling; use of the Prime Broker to hold assets;

sensitivity to interest rates; reliance on the Manager and Investment Manager; conflicts of interest; risks related to dilution; loss of investment; risks relating to currency exposure; risks relating to foreign market exposure; lack of operating history; risks

related to the exchange option; and tax risks. These risk factors are not intended to represent a complete list of the factors that could affect the Corporation and investors are cautioned to consider these and other factors, uncertainties and potential

events carefully and not to put undue reliance on forward-looking statements.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of

providing information about management’s expectations and plans relating to the future. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or

otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.

Terms undefined herein have the meanings ascribed to them in the Prospectus. An investor should rely only on the information contained in the Prospectus. This presentation is qualified in its entirety by reference to, and must be read in conjunction

with, the detailed information appearing in the Prospectus. Neither the Corporation nor the Agent has authorized anyone to provide investors with different or additional information. The Corporation is not offering, or soliciting offers to acquire, the

securities in any jurisdiction in which the offer is not permitted. For purchasers outside Canada, neither the Corporation nor the Agent have done anything that would permit the offering or distribution of this presentation together with the Prospectus in

any jurisdiction where action for that purpose is required, other than in Canada. An investor is required to inform itself about and to observe any restrictions relating to the planned public offering and the distribution of this presentation and of the

Prospectus.

No securities regulatory authority has expressed an opinion about the securities of the Corporation discussed in this presentation and it is an offence to claim otherwise. The securities of the Corporation discussed in this presentation have not been,

and will not be, registered under the U.S. Securities Act, or the securities laws of any state of the United States and, subject to certain exceptions, may not be offered, sold or delivered, directly or indirectly, in the United States except pursuant to an

exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This presentation does not constitute an offer to sell or solicitation of an offer to buy any of the securities of the Trust in the United States.

An investment in the securities offered by the Prospectus must be considered speculative as the securities are subject to certain risk factors as set out under the heading “Risk Factors” in the Prospectus or otherwise described in the Prospectus. An

investment in Units of the Corporation is appropriate only for investors who have the capacity to absorb a loss of some or all of their investment. Investors should also review the financial statements included in the Prospectus.

cgocorp.com 2

cgocorp.com 3

Our Vision

Our goal was to create a vehicle that would take the

guess work out of cannabis investing, and create an

easy, less volatile entry point for new investors into this

rapidly growing and fast changing sector

• We have made the right decisions to stay ahead of the curve

• We have taken a prudent approach to our private portfolio, where

we now see significant gains paying off

• We have created a vehicle suited for not only the average retail

investor, but for anyone looking for true diversification in cannabis

in order to achieve long-term success

cgocorp.com 4

Our Value Proposition

Long-term Success in Cannabis

Diversification: A diversified and actively managed portfolio investing in both public and private cannabis companies globally

Gateway to the US: Ability to take advantage of significant valuation discrepancies with early access into US private companies

Global Reach: Ability to invest globally and be a first mover in the global emerging markets

Smart Capital: Pre-IPO deal flow through our network effect –supporting sustainable deal flow from the extended network

cgocorp.com 5

The Cannabis Industry Opportunity

Cannabis Value Chain

Suppliers

Production

Consumer Products

Retail & Distribution

ServicesCannabinoid Therapeutics

Finance

Real Estate

Hemp Products

CGOC has also

invested in

Traditional

Industry

Investing across

the ecosystem

multiplies the

potential

cgocorp.com 6

US Investments

CGOC is your gateway to the US cannabis market• Unique access to private US Cannabis investment opportunities

• Strong industry connections providing proprietary deal flow

• CGOC Network Effect in full force south of the border

Private US Investments across 18 states

cgocorp.com 7

The CGOC Network Effect

CGOC

Creating value that results in proprietary deal flow

Investors

Private

Co’s

Public

Co’s

Gain exposure to more

sophisticated institutional

shareholders

Gain name exposure

to public markets

Partnerships and

M&A opportunities

Gain access to

professionally

managed diversified

portfolio

Gain access to

private investments

Gain strategic advisory

from CGOC

cgocorp.com 8

CG

OC

:CS

E

Portfolio Overview• Geographic Breakdown

• Top 10 Public & Private Investments

cgocorp.com 9

Portfolio Breakdown

CGOC helps bring access to key investments in Canada, USA and International markets, driven by its private portfolio.

*Portfolio breakdown at cost

Geographical Breakdown of Public

and Private Portfolios

Breakdown of Investment Split across

the Public and Private Portfolio’s

41%

59%

0%

27%

41%

32%

Percentage of

Private Portfolio

US Canadian International

60%

38%

2%

Percentage of

Public Portfolio

US Canadian International

cgocorp.com 10

Managing the Public Portfolio

2017 -2018Funded Capacity and Rec

2015-2016Cultivation and

Medical

2019 and Beyond

Extracted Products, CPG, R.O.W.

2018 -2019Rec and Supply Agreements, USA

Evolution of the Portfolio

cgocorp.com 11

Upcoming Catalysts

Areas to Watch

Canada• Sales – Ramp Up, Retail, Products

• Extracted Product Regulations – Who is ready, Who will lead?

• M&A – Size, Strategy, Diversification

United States• CBD – Hype or Dwindle

• Legislation SAFE and STATEs – What do they mean to the portfolio

• M&A – Inside and outside the Boarders

International• Europe, Australia, South America

cgocorp.com 12

Top 10 Public Investments

A diversified portfolio of public companies focused on maximizing long-term growth. The public portfolio is actively managed by a seasoned Portfolio Manager, with a focus of staying ahead of the curve.

CSE: BHNG (USA)

Award winning house of

cannabis & hemp brands

Not yet listed (USA)

Vertically integrated

producer in California

CSE: CXXI (USA)


producer of cannabis and

hemp derived consumer

products

CSE: NGW (USA)


producer, known as one of

California’s best consumer

packaged goods brands

Not yet listed (USA)

Grassroots is focused on

vertical integration in limited

licensed medical markets

CSE: PLTH (USA)


cannabis company based in

Nevada, (Planet 13 Cannabis

Entertainment Complex)

CSE: CANN (Canada)


cannabis provider

CSE: TER (Canada)

Provides quality products,

brands and services to

global cannabinoid market

NEX: JUSH.B (USA)

Building a vertically

integrated MSO of cannabis

and hemp licenses

TSX-V: VIVO (Canada)

Pharma and recreational

cgocorp.com 13

Private Portfolio Investments

Our private portfolio companies have seen enormous success and have and continue to positively impact our NAV.

.

Canada

Merchant bank, actively

investing in new and

innovative US enterprises

Canada & US

Cannabis wellness and

lifestyle brand

North Macedonia

Producer of premium

medical cannabis products

for European markets

US (California)

Creating biologically active

and nutrient dense biochar

soils for commercial

agriculture

Canada (Quebec)

World-class cannabis centre

site, supporting cannabis

innovators

Canada

Supporting many top tier

brands in cannabis

US

Facilitates partnerships

between farmers and

consumers

Canada

Consumer healthcare with

products under the brand

SannaTM

Canada

LP furthering the science of

medical cannabis

Canada

A vertically integrated

producer & distributor

Jamaica

Lowest cost producers

globally, located in an ideal

natural climate

Israel

Agri-Co licensed to

produce and supply

medical cannabis

Canada

(Aura Cannabis) An

independent Canadian

cannabis retailer

US (California)

vertically integrated direct-to

consumer

Canada/ Israel

Development and

commercialization of

pharmaceutical cannabis

Canada

Next generation R&D

biopharmaceutical

company

US (California)

Application software

connecting users with

lifestyle brands

Switzerland

Biodynamic agriculture

creating sustainable

organically grown cannabis

products

Canada

Merchant bank, actively

investing in new and

innovative US enterprises

cgocorp.com 14

Private Portfolio – Recent and Pending Events

RECENT GO PUBLIC TRANSACTION

IM Cannabis Corp (formerly I.M.C. Holdings Ltd.) completed its RTO transaction and listed on

the CSE under the symbol “IMCC”, on November 5, 2019, and closed its first day of trading at

$0.63.

CGOC invested $250,000 CAD in IMCC in May of 2018, receiving 62,500 common shares

and 31,250 warrants.

IM Cannabis is a leading medical cannabis provider. Since 2010, the company has offered a full spectrum of government-

licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients.

IMCC is an industrial innovator, constantly moving forward in the rapidly developing medical cannabis market and closely

collaborating with research institutions and start-up companies. IMCC is based in Israel & expanding internationally, currently

focusing on the EU market. IMC initiated its strategy by acquiring a pharmaceutical distribution company in Germany with all

licenses required for distribution of medical cannabis throughout Europe. IMC’s supply of EU-GMP pharma-grade medical

cannabis products is available from a variety of sources, both EU cultivation farms, as well as Israeli farms. IMC has formed

strong strategic alliances within the international medical cannabis industry and has developed a long-term, IP-protected

product portfolio.

cgocorp.com 15

Private Portfolio – Case Study of Meaningful Acquisitions

Feb/ 2018 - investment of $450,000 for

175,000 shares at $2.75 per share.

May 30/2018 Harvest One acquired

DreamWater for a combination of cash

and shares with a total value of $34.5

million.

ROI of 55% in 3 months

Apr/2018 – investment of $2,009,000

for 205 common shares at $9,800 per

share.

On March 4, 2019, Aurora Cannabis

completed the acquisition of Whistler

Medical payable in three tranches,

subject to certain milestones.

Total ROI will be calculated

once final tranche is paid

cgocorp.com 16

Private Portfolio – Case Study of Meaningful Liquidity Events

Aug/ 2018 – Initial investment of

$750,000 for 1,250,000 unites at

$0.60 per unit.

Completed its RTO transaction to

commence trading on the CSE under

the symbol “NGW”, on Oct/10/2018

Divested of 11%, remainder is still held

in public portfolio.

ROI of 38% in 3 months ROI of 188% in 9 months

Jul/ 2018 – Initial investment of

$1,971,710 for 33,500 units at $57.23

per unit.

Vireo completed its RTO transaction

and commenced trading on the CSE

under the symbol “VREO”, on March

20, 2019 at an opening price of $5.65

(units converted at exchange ratio of

30.0048 into 1,005,161 common

shares) .

Still held in the public portfolio

Mar/ 2018 – Initial investment of

$1,962,090 for 1,500,000 common

shares & 1,500,000 Warrants.

Jushi completed its RTO transaction

and commenced trading on the NEO

Exchange under the symbol “JUSH.B”,

on June 10, 2019 at a closing price of

$3.20 (only common shares taken into

account in ROI calculation).

Still held in the public portfolio

ROI of 178% in 15 months

cgocorp.com 17

CG

OC

:CS

E

Valuation & Performance• Overview of CGOC performance over time

cgocorp.com 18

Valuation & Performance

• NAV as of Nov/15 = $2.51 performing well

against our benchmarks

• NAV decrease of 9% YTD

• NAV increase of 8% since inception

*HMJR from February 14, 2018,

**Jan 26 starting NAV after agent’s fee $2.3171

CGOC strategy has resulted in portfolio gains and reduced downside

through industry volatility

-0.4

-0.3

-0.2

-0.1

0

0.1

0.2

0.3

Sep 17 VS

Aug 13

Oct 15 VS

Sep 17

Nov 15 VS

Oct 15

Dec 17 VS

Nov 15

Jan 15 VS

Dec 17

Feb 15 VS

Jan 15

Mar 15 VS

Feb 15

Apr 15 VS

Mar 15

May 15 VS

Apr 15

June 14

VS May 15

July 15 VS

June 14

August 15

VS July 15

Sept 16

VS Aug 15

Oct15 VS

Sept 16

HMMJ HMJR NAMMAR CGOC NAV

November 15 VS Inception -61% -71% -67% 8%

-61% -71% -67%

8%

cgocorp.com 19

CGOC Share Price Return

CGOC has outperformed YTD, however recent downward pressure has affected the market as a whole.

cgocorp.com 20

CG

OC

:CS

E

Summary

CGOC.COM

• Additional catalyst events within the private portfolio should positively impact the NAV going forward and demonstrate the opportunity available for investors

• Exposure to both private and public companies with better liquidity than investing directly into the privates

• Global Focus – early participation in emerging cannabis markets (such as Europe)

• Smart Capital – we are offered proprietary deal flow

cgocorp.com 21

CG

OC

:CS

E

APPENDIX

cgocorp.com 22

The CGOC Team

Experienced leadership and operational teamSean Conacher

Director, CEO

Experienced and demonstrated leader working in

the financial services and marketing sectors

skilled in entrepreneurship, venture capital, public

and private equity, foreign exchange, options and

asset management. CEO and founder of GCI

Corporation, a vertically integrated cannabis

company.

Bruce Campbell

Portfolio Manager

24+ years of investment

management experience and an

active cannabis investor since 2013.

Founder and Portfolio Manager of

Stone Castle Investment

Management

Paul Andersen, CPA, CA

Director & CFO

Over 20 years of experience as a senior officer and/or director of numerous public and private. Cannabis-specific

experience and currently serves as director of Canada House Wellness Group Inc., and has worked as a

consultant with a privately owned Oregon-based cannabis company.

Nick J. Richards

Independent Director

Practicing tax attorney, adjunct professor of law and legal specialist to the United States cannabis industry,

advising businesses and owners throughout the U.S., and is licensed to practice law in California and Colorado.

Brayden Sutton


Co-founded and served as EVP for Supreme Pharmaceuticals from 2013 – 2014 and played an instrumental role

in the early days of Invictus MD Strategies Corp., Aurora Cannabis Inc. and CannaRoyalty Corp. Throughout his

career, Mr. Sutton has played a major role in restructurings, reverse takeovers, IPOs and M&As

John Durfy


25+ years of senior investment and financial management experience. Previously CIO at a hedge fund and prior

to that, Managing Director of Global Equities for the Ontario Municipal Employees Retirement System (“OMERS”)

from 2008-2011.

Gary Yeoman


From 2005 to 2011, Mr. Yeoman served as the CEO of Altus Group, and led the company through a seven-year

growth period. Previously Chairman of the board of Golden Leaf Holdings and Executive Chair of iLOOKABOUT.

Jamie Blundell

Director, President & COO

25+ years of experience in

senior leadership roles,

extensive experience with

M&A, private equity firms and

large corporate divestitures.

cgocorp.com 23

The CGOC Difference

The Cannabis Growth Opportunity CorporationAccess to the knowledge and expertise needed to build and grow a diversified portfolio of public and private investments globally, to minimize downside risk, while participating in the long-term upside.

A portfolio of

Public Cannabis Businesses

• Diversified to minimize downside

• Actively managed

• Global focus

• ~60% of invested capital

A portfolio of

Private Cannabis Businesses

• Unique access

• Global focus

• Target 12-24 month liquidity

• ~40% of invested capital

cgocorp.com 24

The Cannabis Industry Opportunity

Investing across the whole ecosystem multiplies the potential• $12B Canadian Cannabis industry estimate based on base market business models: cultivation and

extraction(1)

• The whole ecosystem projected to reach $23B, after factoring in ancillary services shown below(2)

(1) Source: Latest Research reports from Cowen and Company

(2) Source: Deloitte

Suppliers

Seeds, fertilizers,

etc.

Production

CultivationResearch and

developmentExtraction

Analytical

equipment &

services

Production

equipment,

security &

infrastructure

Software

Retail and Distribution

Online /

ecommerce

Stores,

consumption

locations

Consumer Products

Flower and

oil extracts

Edibles, tinctures,

topicals, infused

etc.

Delivery Systems

(vaporizers,

pipes, rolling

papers, etc.)

ApparelPackaging &

distribution

Services

Buildings,

equipment

Business,

regulatory, legal,

etc.

Marketing Pharmaceuticals Nutraceuticals Fiber, seeds, food

Cannabinoid

TherapeuticsFinance

Real

EstateHemp

Capital,

structuring

CGOC has also

invested in

Traditional

Industry

cgocorp.com 25

Canada and the US

➢ A total of 33 states have legalized medicinal marijuana, and 10 states have legalized recreational

use

➢ The US continues to be a driving force in production and consumption with California being the

second largest market globally

➢ US MARKET SHARE alone expected to account for US$63 Billion at maturity

Upcoming Catalysts:

➢ The STATES Act, is expected to pass in 2019 – which will grant regulatory power to the individual

states

➢ SAFE (Secure And Fair Enforcement) Banking act has 20 cosponsors in the Senate, and would

protect banks and other institutions from federal prosecution when working with cannabis-related

business.

US States Continue to Move Towards Legalization

Canadian Developments

➢ Ahead of the legalization of extracted goods (such as edibles, vapes and infused

beverages), many Canadian companies are in the midst of intense R&D and product

roll out, as well as partnering with known brands in the US for supply control and

brand recognition

➢ Canadian market expected to remain undersupplied until 2020

* source: Eight Capital

cgocorp.com 26

The Global Picture

* source: Eight Capital

International Developments

➢ Medical Cannabis now officially regulated in over 50 countries world-wide,

with more than 2 dozen of these centered within Europe

➢ Columbia and Israel have approved the exportation of cannabis

➢ Europe is opening up with many countries rapidly adapting their laws and

adopting medical use cannabis

GLOBAL CANNABIS MARKET anticipated to be worth US$170 Billion across

a 10-15 year time horizon

The global landscape is changing rapidly, creating competition for control of supply

of both THC and CBD; proprietary extraction methods, recipes and formulas being

readily sought after; and one of the biggest brand creation and recognition battles

of all time.

cgocorp.com 27

Staying Ahead of the Curve

Technicals Lead Price

April 2018

January 2019 January 2019

Technicals - Time for a Rest?

April 2019

cgocorp.com 28

A Changing Environment Requires ContinuousMonitoring of Information

Keeping up to date on a fast-changing environment on the regulatory as well as investor sentiment side – We stay in the know!

Rapid regulatory change (local & global)

Implication

Key investing behaviors required to succeed:

Active management, access to privates,

timing investments

US market attractiveness increasing

Reasons

Experienced operators + meaningful REV & EBITDA

US capital is starting to increase rapidly

Implication

Need to focus & actively invest in US privates

Privates need help navigating capital markets

Implication

Continue to focus and build capabilities to help

privates access, navigate and succeed with the capital

markets and M&A opportunities

CGOC network effect working

Implication

Continue to connect investors, publics and privates and

drive the CGOC network effect: trust

delivering long-term success in cannabis...

Documents